Please login to the form below

Not currently logged in
Email:
Password:

company strategy

This page shows the latest company strategy news and features for those working in and with pharma, biotech and healthcare.

Pharma Brand Planners' Blog (Part 3)

Pharma Brand Planners' Blog (Part 3)

It’s also worth making a few distinctions: strategy does not mean tactics! ... Strategy is often defined as the ‘how’, the decisions that will drive the allocation of tactics and resources and create sustainable competitive advantage for the brand

Latest news

  • Hal Barron touts new drive to improve GSK’s research output Hal Barron touts new drive to improve GSK’s research output

    to developing drugs at the company – and is hoping to see a new bold approach pay dividends. ... He also indicated GSK’s interest in cell and gene therapies – another reversal on previous strategy, where the company had sold off its Strimvelis gene

  • Oxford Biomedica gets £53m cash injection from Novo venture arm Oxford Biomedica gets £53m cash injection from Novo venture arm

    The company is pursuing a dual strategy of supporting partners in the development and commercialisation of their gene and cell therapy programmes, while at the same time developing its own ... By clearing its Oaktree Capital Management debt, the company

  • The Communiqué Awards: what are judges looking for? The Communiqué Awards: what are judges looking for?

    That’s why you have a strategy and set objectives because they can drive you on to great creativity.”. ... Among the judges were a senior leader in a behaviour change agency, a brand manager from a major pharma company, an SVP from a strategy agency,

  • UCB signs research deal with King’s College London UCB signs research deal with King’s College London

    The shared workspace initiative builds on UCB’s global satellite search site strategy, which aims to embed company scientists within global centres of excellence. ... The biopharma company has already used the same approach in three US sites, resulting

  • Hardy returns to Genentech as CEO Hardy returns to Genentech as CEO

    Smith, who was the company’s chief operating officer, initially joined the company in 2001 from Ernst &Young. ... In 2019 and beyond, I am confident that we will continue to successfully execute the company’s long-standing strategy to bring

More from news
Approximately 51 fully matching, plus 129 partially matching documents found.

Latest Intelligence

  • The rise of CEO activism The rise of CEO activism

    strategy. In recent years, the rise of ‘CEO activism’ has seen business leaders take a stand on political or social issues that are not necessarily related to their business. ... of an issue can help bolster loyalty and trust in a company, or deepen

  • New models of NHS care – new models of pharma response? New models of NHS care – new models of pharma response?

    Novartis’ collaborative culture. Fiona Bride. Fiona Bride, Director of Market Access Strategy, Novartis, says her company has shifted its culture to try to align as much as possible with healthcare providers,

  • How pharma should navigate Artificial Intelligence (AI) How pharma should navigate Artificial Intelligence (AI)

    Leaders need to develop an AI strategy that cuts through the hype and matches each company’s unique situation’. ... Given its clear benefits, leaders need to develop an AI strategy that cuts through the hype and matches each company’s unique

  • Revenue down the back of the beanbag Revenue down the back of the beanbag

    Transparency of the long-term business strategy, communication of company performance and creation of vehicles for shared wealth generation (such as well-designed bonus schemes and all employee stock plans) will ... so. Assuming that a graduate or

  • Understanding HCPs to build a meaningful brand Understanding HCPs to build a meaningful brand

    Net sentiment is the total of all such sentiment values assigned to mentions of the company. ... All those patients and HCPs that were among the most-mentioned Twitter accounts by pharmaceutical companies were also involved with the companies offline,

More from intelligence
Approximately 4 fully matching, plus 33 partially matching documents found.

Latest appointments

  • New hires at Ferring, Flexion and Immunocore New hires at Ferring, Flexion and Immunocore

    Flexion Therapeutics names chief strategy officer. Biopharmaceutical company Flexion Therapeutics has named Christina Willwerth as its chief strategy officer. ... Willwerth joined Flexion back in 2009 and most recently served as the company’s senior

  • Chameleon reveals new leadership line-up Chameleon reveals new leadership line-up

    He will report into Matt D’Auria, chief executive of Chameleon’s parent company Healthcare Consultancy Group. ... The company’s US executive vice president of commercial development, Guy Slatcher now moves into the role of president, Chameleon US.

  • Exelixis appoints Andrew Peters to newly created position Exelixis appoints Andrew Peters to newly created position

    In this newly created role, Peters will work with the Exelixis leadership team to refine the company’s mid- and long-term strategy, which is focused on advancing the next generation ... team as we work to identify potential future growth opportunities

  • Sue Mahony to retire as president of Lilly Oncology Sue Mahony to retire as president of Lilly Oncology

    She also most recently led the refocusing of the company’s oncology R&D strategy. ... Prior to this, as senior vice president of human resources and diversity, Mahony played in a role in restructuring the company into business units.

  • Neurimmune appoints chief business officer Neurimmune appoints chief business officer

    Fabian Buller will further drive the biopharma’s growth strategy. Monoclonal antibody-focused Neurimmune has appointed Fabian Buller into the newly created role of chief business officer. ... Roger Nitsch, president and CEO of Neurimmune, said: “We

More from appointments
Approximately 0 fully matching, plus 62 partially matching documents found.

Latest from PMHub

  • Spotlight interview: 15 minutes on patient engagement in pharma

    We run cross-functional working groups within the pharmaceutical company, and we facilitate and run co-creation meetings between pharmaceutical clients, patient advocacy groups, and patients. ... Both approaches will help determine what the correct and

  • Valid Insight wins the Queen’s Most Coveted Award for Enterprise

    Today, Her Majesty the Queen announced approval of the Prime Minister’s recommendation for Valid Insight to be honoured in recognition of the outstanding success of the company’s growth strategy. ... Since being established in 2016, the company has

  • Investing in our People

    A group of people who, when it counts, pull together. Last weekend the team went to Palma, Majorca where we held a workshop and meeting to discuss company strategy and how

  • Practical Patient Centricity

    about their medicine is alien to us”.It is not just company strategy and intent that is the driving force for a more patient centric approach: external pressure is also building ... These may be outside the current scope of the company’s business, so

  • GK Strategy

    Company Details.

More from PMHub
Approximately 0 fully matching, plus 15 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anatomy Health

We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics